BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 12959735)

  • 1. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
    Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents.
    Huang Y; Wang L; Verweire I; Qiang B; Liu X; Verbeken E; Schacht E; De Scheerder I
    J Invasive Cardiol; 2002 Sep; 14(9):505-13. PubMed ID: 12205348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.
    Kipshidze NN; Iversen P; Kim HS; Yiazdi H; Dangas G; Seaborn R; New G; Tio F; Waksman R; Mehran R; Tsapenko M; Stone GW; Roubin GS; Iyer S; Leon MB; Moses JW
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):518-27. PubMed ID: 15065150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer stent coating for prevention of neointimal hyperplasia.
    Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
    J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model.
    Huang Y; Salu K; Wang L; Liu X; Li S; Lorenz G; Wnendt S; Verbeken E; Bosmans J; Van de Werf F; De Scheerder I
    J Invasive Cardiol; 2005 Mar; 17(3):142-8. PubMed ID: 15867441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: inhibition through reduction of inflammation?
    Carlier SG; van Damme LC; Blommerde CP; Wentzel JJ; van Langehove G; Verheye S; Kockx MM; Knaapen MW; Cheng C; Gijsen F; Duncker DJ; Stergiopulos N; Slager CJ; Serruys PW; Krams R
    Circulation; 2003 Jun; 107(21):2741-6. PubMed ID: 12742998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
    Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
    Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model.
    Hou D; Narciso H; Kamdar K; Zhang P; Barclay B; March KL
    Cardiovasc Intervent Radiol; 2005; 28(1):60-5. PubMed ID: 15719180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
    Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
    Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
    Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent-mediated methylprednisolone delivery reduces macrophage contents and in-stent neointimal formation.
    Wang L; Salu K; Verbeken E; Bosmans J; Van de Werf F; De Scheerder I; Huang Y
    Coron Artery Dis; 2005 Jun; 16(4):237-43. PubMed ID: 15915076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model.
    De Scheerder I; Szilard M; Yanming H; Ping XB; Verbeken E; Neerinck D; Demeyere E; Coppens W; Van de Werf F
    J Invasive Cardiol; 2000 Aug; 12(8):389-94. PubMed ID: 10953100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
    Kipshidze NN; Porter TR; Dangas G; Yazdi H; Tio F; Xie F; Hellinga D; Wolfram R; Seabron R; Waksman R; Abizaid A; Roubin G; Iyer S; Colombo A; Leon MB; Moses JW; Iversen P
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):389-94. PubMed ID: 15736246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
    Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.